In a filing, Nexalin Technology Inc revealed its Sr. VP – Quality, Regulatory Shelton Carolyn Hamby acquired Company’s shares for reported $13200.0 on Mar 12 ’25. In the deal valued at $2.20 per share,6,000 shares were bought. As a result of this transaction, Shelton Carolyn Hamby now holds 30,000 shares worth roughly $25500.0.
Then, Owens David bought 1,000 shares, generating $3,100 in total proceeds. Upon buying the shares at $3.10, the Chief Medical Officer now owns 155,793 shares.
Before that, Owens David bought 1,000 shares. Nexalin Technology Inc shares valued at $2,980 were divested by the Chief Medical Officer at a price of $2.98 per share. As a result of the transaction, Owens David now holds 154,793 shares, worth roughly $0.13 million.
Price Performance Review of NXL
On Tuesday, Nexalin Technology Inc [NASDAQ:NXL] saw its stock jump 1.52% to $0.85. Over the last five days, the stock has gained 13.09%. Nexalin Technology Inc shares have fallen nearly -11.35% since the year began. Nevertheless, the stocks have fallen -69.32% over the past one year. While a 52-week high of $4.49 was reached on 02/05/25, a 52-week low of $0.59 was recorded on 08/21/25.
Levels Of Support And Resistance For NXL Stock
The 24-hour chart illustrates a support level at 0.8085, which if violated will result in even more drops to 0.7702. On the upside, there is a resistance level at 0.8875. A further resistance level may holdings at 0.9282.
How much short interest is there in Nexalin Technology Inc?
A steep rise in short interest was recorded in Nexalin Technology Inc stocks on 2025-08-15, dropping by 22153.0 shares to a total of 46125.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 68278.0 shares. There was a decline of -48.03%, which implies that there is a negative sentiment for the stock.
